Cargando…

WWOX-rs13338697 genotype predicts therapeutic efficacy of ADI-PEG 20 for patients with advanced hepatocellular carcinoma

BACKGROUND: Previous studies have identified three single nucleotide polymorphisms (SNPs): GALNT14-rs9679162, WWOX-rs13338697 and rs6025211. Their genotypes are associated with therapeutic outcomes in hepatocellular carcinoma (HCC). Herein, we examined whether these SNP genotypes could predict the c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chu, Yu-De, Liu, Hui-Fen, Chen, Yi-Chen, Chou, Chun-Hung, Yeh, Chau-Ting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756969/ https://www.ncbi.nlm.nih.gov/pubmed/36530994 http://dx.doi.org/10.3389/fonc.2022.996820

Ejemplares similares

Efficacy of arginine depletion by ADI-PEG20 in an intracranial model of GBM
por: Przystal, Justyna Magdalena, et al.
Publicado: (2018)

A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients
por: Yang, T-S, et al.
Publicado: (2010)

Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers
por: Chang, Kwang-Yu, et al.
Publicado: (2021)

A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients
por: Tsai, Hui-Jen, et al.
Publicado: (2017)

Association of WWOX rs9926344 polymorphism with poor prognosis of hepatocellular carcinoma
por: Chen, Wanyong, et al.
Publicado: (2018)

Phase I study of ADI‐PEG20 plus low‐dose cytarabine for the treatment of acute myeloid leukemia
por: Tsai, Hui‐Jen, et al.
Publicado: (2021)

Phase 1 trial of ADI‐PEG 20 and liposomal doxorubicin in patients with metastatic solid tumors
por: Yao, Shuyang, et al.
Publicado: (2021)

Discovery and Targeting of a Noncanonical Mechanism of Sarcoma Resistance to ADI-PEG20 Mediated by the Microenvironment
por: Rogers, Leonard C., et al.
Publicado: (2023)

Hypoxia-induced nitric oxide production and tumour perfusion is inhibited by pegylated arginine deiminase (ADI-PEG20)
por: Burrows, Natalie, et al.
Publicado: (2016)

Tumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas
por: Chiang, Ming-Fu, et al.
Publicado: (2013)

Decreased argininosuccinate synthetase expression in Thai patients with cholangiocarcinoma and the effects of ADI-PEG20 treatment in CCA cell lines
por: Roeksomtawin, Somphon, et al.
Publicado: (2018)

Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignancies
por: Yao, Shuyang, et al.
Publicado: (2021)

A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma
por: Phillips, Melissa M., et al.
Publicado: (2023)

WWOX rs11644322 Polymorphism, Gemcitabine, and Pancreatic Cancer
por: Yasri, Sora, et al.
Publicado: (2017)

A Phase 1 study of ADI‐PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1‐negative metastatic uveal melanoma
por: Chan, Pui Ying, et al.
Publicado: (2022)

Correction: A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma
por: Phillips, Melissa M., et al.
Publicado: (2023)

Modeling WWOX Loss of Function in vivo: What Have We Learned?
por: Tanna, Mayur, et al.
Publicado: (2018)

Adi Armoni
por: Armoni, Adi
Publicado: (2022)

Adie's Syndrome
por: Marmion, Vincent
Publicado: (1975)

Normal cells repel WWOX-negative or -dysfunctional cancer cells via WWOX cell surface epitope 286-299
por: Chen, Yu-An, et al.
Publicado: (2021)

WWOX Tumor Suppressor Gene in Breast Cancer, a Historical Perspective and Future Directions
por: Pospiech, Karolina, et al.
Publicado: (2018)

Evodiamine Exerts an Anti-Hepatocellular Carcinoma Activity through a WWOX-Dependent Pathway
por: Hu, Che-Yuan, et al.
Publicado: (2017)

The ADI model problem
por: Wachspress, Eugene
Publicado: (2013)

Adie’s Tonic Pupil
por: Kanzaria, Hemal K, et al.
Publicado: (2012)

Pupila de Adie
por: Babiano Fernandez, Miguel Angel
Publicado: (2020)

WWOX Phosphorylation, Signaling, and Role in Neurodegeneration
por: Liu, Chan-Chuan, et al.
Publicado: (2018)

Wwox Deletion in Mouse B Cells Leads to Genomic Instability, Neoplastic Transformation, and Monoclonal Gammopathies
por: McBride, Kevin M., et al.
Publicado: (2019)

Delineating WWOX Protein Interactome by Tandem Affinity Purification-Mass Spectrometry: Identification of Top Interactors and Key Metabolic Pathways Involved
por: Hussain, Tabish, et al.
Publicado: (2018)

The methionine salvage pathway-involving ADI1 inhibits hepatoma growth by epigenetically altering genes expression via elevating S-adenosylmethionine
por: Chu, Yu-De, et al.
Publicado: (2019)

Neonatal neuronal WWOX gene therapy rescues Wwox null phenotypes
por: Repudi, Srinivasarao, et al.
Publicado: (2021)

Cancerous Protein Network That Inhibits the Tumor Suppressor Function of WW Domain-Containing Oxidoreductase (WWOX) by Aberrantly Expressed Molecules
por: Saigo, Chiemi, et al.
Publicado: (2018)

WWOX Possesses N-Terminal Cell Surface-Exposed Epitopes WWOX(7-21) and WWOX(7-11) for Signaling Cancer Growth Suppression and Prevention In Vivo
por: Wang, Wan-Jen, et al.
Publicado: (2019)

Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk
por: Lee, Hsiang-Lin, et al.
Publicado: (2017)

Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma
por: Park, S-W, et al.
Publicado: (2004)

WWOX and Its Binding Proteins in Neurodegeneration
por: Hsu, Che-Yu, et al.
Publicado: (2021)

ADI1, a methionine salvage pathway enzyme, is required for Drosophila fecundity
por: Chou, He-Yen, et al.
Publicado: (2014)

Reversal of Hyperglycemia and Suppression of Type 1 Diabetes in the NOD Mouse with Apoptotic DNA Immunotherapy™ (ADi™), ADi-100
por: Alleva, David G., et al.
Publicado: (2020)

Strategies by which WWOX-deficient metastatic cancer cells utilize to survive via dodging, compromising, and causing damage to WWOX-positive normal microenvironment
por: Chou, Pei-Yi, et al.
Publicado: (2019)

Child–Pugh Score and ABCG2-rs2231142 Genotype Independently Predict Survival in Advanced Hepatoma Patients Treated with Sorafenib
por: Huang, Po-Han, et al.
Publicado: (2022)

Fragile Gene WWOX Guides TFAP2A/TFAP2C-Dependent Actions Against Tumor Progression in Grade II Bladder Cancer
por: Kołat, Damian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fk6jtdk7o7u5ueonag0qoc5ush